Regulus Therapeutics Stock Market Value
| RGLS Stock | USD 1.61 0.03 1.83% |
| Symbol | Regulus |
Regulus Therapeutics Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Regulus Therapeutics. If investors know Regulus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Regulus Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.02) | Revenue Per Share 0.071 | Quarterly Revenue Growth 276.778 | Return On Assets (0.42) | Return On Equity (0.72) |
The market value of Regulus Therapeutics is measured differently than its book value, which is the value of Regulus that is recorded on the company's balance sheet. Investors also form their own opinion of Regulus Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Regulus Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Regulus Therapeutics' market value can be influenced by many factors that don't directly affect Regulus Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Regulus Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Regulus Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Regulus Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Regulus Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Regulus Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Regulus Therapeutics.
| 11/01/2024 |
| 12/01/2024 |
If you would invest 0.00 in Regulus Therapeutics on November 1, 2024 and sell it all today you would earn a total of 0.00 from holding Regulus Therapeutics or generate 0.0% return on investment in Regulus Therapeutics over 30 days. Regulus Therapeutics is related to or competes with Tenax Therapeutics, Verastem, Pulmatrix, and Cellectar Biosciences. Regulus Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of drugs... More
Regulus Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Regulus Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Regulus Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 4.25 | |||
| Information Ratio | (0.02) | |||
| Maximum Drawdown | 17.58 | |||
| Value At Risk | (6.41) | |||
| Potential Upside | 7.19 |
Regulus Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Regulus Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Regulus Therapeutics' standard deviation. In reality, there are many statistical measures that can use Regulus Therapeutics historical prices to predict the future Regulus Therapeutics' volatility.| Risk Adjusted Performance | 0.0151 | |||
| Jensen Alpha | (0.09) | |||
| Total Risk Alpha | (0.66) | |||
| Sortino Ratio | (0.02) | |||
| Treynor Ratio | 0.0295 |
Regulus Therapeutics Backtested Returns
Currently, Regulus Therapeutics is very risky. Regulus Therapeutics maintains Sharpe Ratio (i.e., Efficiency) of 0.0297, which implies the firm had a 0.0297% return per unit of risk over the last 3 months. We have found thirty technical indicators for Regulus Therapeutics, which you can use to evaluate the volatility of the company. Please check Regulus Therapeutics' Risk Adjusted Performance of 0.0151, semi deviation of 3.81, and Coefficient Of Variation of 10975.75 to confirm if the risk estimate we provide is consistent with the expected return of 0.12%. Regulus Therapeutics has a performance score of 2 on a scale of 0 to 100. The company holds a Beta of 0.94, which implies possible diversification benefits within a given portfolio. Regulus Therapeutics returns are very sensitive to returns on the market. As the market goes up or down, Regulus Therapeutics is expected to follow. Regulus Therapeutics right now holds a risk of 4.11%. Please check Regulus Therapeutics downside variance, and the relationship between the sortino ratio and accumulation distribution , to decide if Regulus Therapeutics will be following its historical price patterns.
Auto-correlation | 0.24 |
Weak predictability
Regulus Therapeutics has weak predictability. Overlapping area represents the amount of predictability between Regulus Therapeutics time series from 1st of November 2024 to 16th of November 2024 and 16th of November 2024 to 1st of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Regulus Therapeutics price movement. The serial correlation of 0.24 indicates that over 24.0% of current Regulus Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.24 | |
| Spearman Rank Test | 0.42 | |
| Residual Average | 0.0 | |
| Price Variance | 0.01 |
Regulus Therapeutics lagged returns against current returns
Autocorrelation, which is Regulus Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Regulus Therapeutics' stock expected returns. We can calculate the autocorrelation of Regulus Therapeutics returns to help us make a trade decision. For example, suppose you find that Regulus Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Regulus Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Regulus Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Regulus Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Regulus Therapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
Regulus Therapeutics Lagged Returns
When evaluating Regulus Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Regulus Therapeutics stock have on its future price. Regulus Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Regulus Therapeutics autocorrelation shows the relationship between Regulus Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in Regulus Therapeutics.
Regressed Prices |
| Timeline |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Regulus Stock Analysis
When running Regulus Therapeutics' price analysis, check to measure Regulus Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Regulus Therapeutics is operating at the current time. Most of Regulus Therapeutics' value examination focuses on studying past and present price action to predict the probability of Regulus Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Regulus Therapeutics' price. Additionally, you may evaluate how the addition of Regulus Therapeutics to your portfolios can decrease your overall portfolio volatility.